Australia markets closed

Allergy Therapeutics plc (AGY.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
6.25+1.25 (+25.00%)
At close: 12:33PM GMT
Full screen
Previous close5.00
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's range0.00 - 0.00
52-week range
Volume0
Avg. volume95,449
Market cap42.444M
Beta (5Y monthly)1.00
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Interim Results for the six months ended 31 December 2021

    Allergy Therapeutics plc(“Allergy Therapeutics” or the “Company” or the “Group”) Interim Results for the six months ended 31 December 2021 ~ US readiness plan underway including two pivotal trials Portfolio focused on high value growth products to enhance future profitabilityGround-breaking Phase I trial of peanut allergy vaccine on track to commence in 2022 following recent FDA clearance of IND application with data expected sooner than previously anticipatedPivotal Phase III trial of short-cou